Source:http://linkedlifedata.com/resource/pubmed/id/16898488
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2006-8-10
|
pubmed:abstractText |
Fetuin A, 59 kDa protein, produced in the liver is a circulating inhibitor of vascular calcification. The aim of the study was to estimate a concentration of fetuin A in children with renal diseases. Fifty three children were examined: 18 with idiopathic nephrotic syndrome (NS) aged 2.5 to 14.5 years, mean 6.6 +/- 3.6 and 35 with chronic renal failure (CRF) aged 4.5 to 20 years, mean 13.3 +/- 3.9. The control group (K) consisted of 22 healthy children, aged from 6.5 to 17.5 years, mean 10.8 +/- 3.3. In all children serum concentration of fetuin A (ELISA method, BioVendor), calcium (sCa), phosphorus (sP), protein (P), albumin (Alb), total cholesterol (TC) and triglycerides (TG) were measured. The daily protein excretion in children with proteinuria (mg/kg/day) and the serum parathormone (PTH) level in children with CRF were analysed. RESULTS: The concentration of fetuin A was the lowest in children with NS (78.1 +/- 24.5 ng/ml) and was statistically different (p=0.0003) than in group K (101.4 +/- 11 ng/ml) and group CRF (106.7 +/- 13.7 ng/ml). In group NS significant correlations were found between concentrations of fetuin A and sCa (r=0.62, p<0.01), P (r=0.59, p= 0.01) and Alb (r=0.64, p<0.01) and negative correlations with concentration of TC (r=-0.68, p<0.01) and daily proteinuria (r=-0.79, p<0.001). In groups K and CRF the correlations of fetuin A level and analysed parameters were not found. CONCLUSION: Low concentration of fetuin A in children with nephrotic syndrome may be the additional agent to promote the atherogenic lesions.
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-2240
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63 Suppl 3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
54-6
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16898488-Adolescent,
pubmed-meshheading:16898488-Adult,
pubmed-meshheading:16898488-Atherosclerosis,
pubmed-meshheading:16898488-Biological Markers,
pubmed-meshheading:16898488-Blood Proteins,
pubmed-meshheading:16898488-Calcinosis,
pubmed-meshheading:16898488-Child,
pubmed-meshheading:16898488-Child, Preschool,
pubmed-meshheading:16898488-Female,
pubmed-meshheading:16898488-Humans,
pubmed-meshheading:16898488-Kidney Failure, Chronic,
pubmed-meshheading:16898488-Male,
pubmed-meshheading:16898488-Nephrotic Syndrome,
pubmed-meshheading:16898488-Risk Factors,
pubmed-meshheading:16898488-alpha-2-HS-Glycoprotein
|
pubmed:year |
2006
|
pubmed:articleTitle |
[Fetuin A in children with renal diseases].
|
pubmed:affiliation |
Katedra i Klinika Pediatrii i Nefrologii, Akademii Medycznej w Warszawie. nefrologia@litewska.edu.pl
|
pubmed:publicationType |
Journal Article,
English Abstract,
Controlled Clinical Trial
|